ATE197396T1 - Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung - Google Patents

Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung

Info

Publication number
ATE197396T1
ATE197396T1 AT95925470T AT95925470T ATE197396T1 AT E197396 T1 ATE197396 T1 AT E197396T1 AT 95925470 T AT95925470 T AT 95925470T AT 95925470 T AT95925470 T AT 95925470T AT E197396 T1 ATE197396 T1 AT E197396T1
Authority
AT
Austria
Prior art keywords
electrotransport
agent
composition
electrical transport
transdermal electrical
Prior art date
Application number
AT95925470T
Other languages
English (en)
Inventor
J Richard Gyory
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE197396T1 publication Critical patent/ATE197396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
AT95925470T 1994-07-13 1995-06-29 Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung ATE197396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27461994A 1994-07-13 1994-07-13
PCT/US1995/008384 WO1996002232A1 (en) 1994-07-13 1995-06-29 Composition and method for enhancing transdermal electrotransport agent delivery

Publications (1)

Publication Number Publication Date
ATE197396T1 true ATE197396T1 (de) 2000-11-11

Family

ID=23048961

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95925470T ATE197396T1 (de) 1994-07-13 1995-06-29 Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung

Country Status (7)

Country Link
US (1) US5668170A (de)
EP (1) EP0804155B1 (de)
JP (2) JP4090072B2 (de)
AT (1) ATE197396T1 (de)
DE (1) DE69519393T2 (de)
ES (1) ES2153485T3 (de)
WO (1) WO1996002232A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4129696A (en) * 1994-11-17 1996-06-17 Alza Corporation Composition and method for enhancing electrotransport agent delivery
JPH11503043A (ja) * 1995-04-07 1999-03-23 ノバルティス・アクチエンゲゼルシャフト 少なくとも２種の被投与物を投与するためのイオン泳動性経皮システム
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
CN1108173C (zh) * 1996-06-12 2003-05-14 阿尔萨公司 含有多元阴离子抗衡离子的治疗剂的改良电转运
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US6775569B2 (en) 1997-11-05 2004-08-10 Hisamitsu Pharmaceutical Co., Inc. Electroporation device for in vivo delivery of therapeutic agents
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
KR20010042875A (ko) * 1998-04-21 2001-05-25 엥펙시오 르쉐르쉬 엥꼬르뽀라시옹 폴록사머 및 추가의 살미생물제를 함유하는 국소용 조성물및 어플리케이터
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US6792306B2 (en) 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
US6477410B1 (en) 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US6347246B1 (en) * 2000-02-03 2002-02-12 Axelgaard Manufacturing Company, Ltd. Electrotransport adhesive for iontophoresis device
US6522918B1 (en) 2000-02-09 2003-02-18 William E. Crisp Electrolytic device
EP1307182B1 (de) * 2000-08-01 2005-03-30 Sanofi-Aventis Pharmazeutische zusammensetzung zur verabreichung von beflotaxone
US7465295B2 (en) * 2000-10-20 2008-12-16 Bergeron Michel G Applicator for the delivery of topical formulations into mucosal cavities
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
EP1440707A4 (de) * 2001-10-31 2006-05-24 Transcutaneous Tech Inc Iontophorese-vorrichtung
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
CA2500713C (en) * 2002-10-04 2012-07-03 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP1633431B1 (de) * 2003-06-02 2008-11-12 Power Paper Ltd. Bausatz, vorrichtung und verfahren zur gesteuerten abgabe eines oxidationsmittels in die haut
JP4728631B2 (ja) * 2004-11-30 2011-07-20 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US7590444B2 (en) * 2004-12-09 2009-09-15 Tti Ellebeau, Inc. Iontophoresis device
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
JP4731931B2 (ja) * 2005-02-03 2011-07-27 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
JP4793806B2 (ja) * 2005-03-22 2011-10-12 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US8386030B2 (en) 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070088331A1 (en) * 2005-08-18 2007-04-19 Transcutaneous Technologies Inc. Method and apparatus for managing active agent usage, and active agent injecting device
RU2008114490A (ru) 2005-09-15 2009-10-20 ТиТиАй ЭЛЛЕБО, ИНК. (JP) Устройство ионтофореза стержневого типа
JP2009509657A (ja) 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
WO2007041526A2 (en) * 2005-09-30 2007-04-12 Transcutaneous Technologies Inc. Iontophoresis apparatus and method to deliver antibiotics to biological interfaces
US7848801B2 (en) 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
KR101200728B1 (ko) 2006-08-09 2012-11-13 인타르시아 세라퓨틱스 인코포레이티드 삼투성 전달 시스템 및 피스톤 조립체
JPWO2008087803A1 (ja) * 2007-01-16 2010-05-06 国立大学法人北海道大学 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
KR101674904B1 (ko) 2009-02-26 2016-11-10 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 중재형 약물전달 시스템과 그 방법
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Fast-setting and / or cessation of substantially unchanged delivery of the product
WO2011046927A1 (en) * 2009-10-13 2011-04-21 Nupathe,Inc. Transdermal methods and systems for the delivery of rizatriptan
US9237961B2 (en) * 2010-04-23 2016-01-19 Medtronic Vascular, Inc. Stent delivery system for detecting wall apposition of the stent during deployment
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9468682B2 (en) 2013-04-05 2016-10-18 Joint-stock company “High Tech” Compositions and methods for enhancing penetration of biologically active substances into tissues or organs
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
MA53353A (fr) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3565580B1 (de) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4992477A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Skin moisturizing composition and method of preparing same
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
NZ237489A (en) * 1990-04-18 1995-07-26 Alza Corp Device for electrotransport and reservoir therefor containing a fatty acid as permeation enhancing agent
US5336692A (en) * 1990-06-28 1994-08-09 Medicis Pharmaceutical Corporation Ointment base and method of use
ATE169826T1 (de) * 1992-01-21 1998-09-15 Macrochem Corp Iontophoretische verbesserte verabreichung von medikamenten
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物

Also Published As

Publication number Publication date
DE69519393D1 (de) 2000-12-14
EP0804155A1 (de) 1997-11-05
ES2153485T3 (es) 2001-03-01
EP0804155B1 (de) 2000-11-08
DE69519393T2 (de) 2001-04-26
JP2007314562A (ja) 2007-12-06
US5668170A (en) 1997-09-16
WO1996002232A1 (en) 1996-02-01
JP4090072B2 (ja) 2008-05-28
JPH10503184A (ja) 1998-03-24

Similar Documents

Publication Publication Date Title
ATE197396T1 (de) Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung
ATE277671T1 (de) Vorrichtung zur verbesserung der transdermalen abnahme von körperflüssigkeiten
DE69623608T2 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
ATE369150T1 (de) Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe
EP0325613A4 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
EP0384266A3 (en) Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents
DE68910520D1 (de) Verfahren zur Verminderung von Hautirritationen bei Anwendung von durchdringungsverstärkenden Arzneimittelzusammensetzungen.
EP0705097A1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
ATE258068T1 (de) Zusammensetzung, vorrichtung und verfahren zur verbesserten elektrotransport-wirkstoffabgabe
PT96021A (pt) Metodo de tratamento de doencas utilizando potenciadores de fluxo transdermico tais como acido e 1-dodecilazacicloheptan-2-ona em combinacao com iontoforese na administracao topica de agentes farmaceuticos
DE3382616T2 (de) Vermittler des durchdringungsvermoegens zur transdermalen verabreichung systemischer wirkstoffe.
EP0164998A3 (de) Mittel und Verfahren zur Erhöhung der transdermalen und transmembranen Penetration topischer und systemischer Wirkstoffe
DE3468166D1 (en) Bone cement applicator
BR9810554A (pt) Aroil piperazinas para regular a atividade sexual
PT87345A (pt) Processo para a fabricacao de um emplastro para a administracao controlada de substancias activas a pele
DE69623155T2 (de) Verfahren zur transdermalen Verabreichung von Medikamenten
EP0416034A4 (en) Penetration enhancers for transdermal delivery of systemic agent
ES8504465A1 (es) Procedimiento para preparar productos antiespasmos.
FI895169A0 (fi) Pappersbestrykning.
DE69613370D1 (de) Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr
ATE20313T1 (de) Elektrotherapeutische vorrichtung.
EP0448299A3 (en) Method and composition for increased skin concentration of active agents by iontophoresis
CA2190370A1 (en) Composition and method for enhancing transdermal electrotransport agent delivery
HK1020525A1 (en) Drug delivery devices and process of manufacture
AU634867B2 (en) Method and composition for iontophoresis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties